Experimental Antiarrhythmic Drug Reduces Death Rate In Patients With Atrial Fibrillation, Study Suggests
Thursday, February 26, 2009 - 05:22
in Health & Medicine
New research suggests that the (as yet unlicensed) antiarrhythmic drug dronedarone can reduce the incidence of cardiovascular-related hospitalization or death in patients with atrial fibrillation.